• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜恶性间皮瘤的当前治疗方法。

Current approach to malignant mesothelioma of the pleura.

作者信息

Aisner J

机构信息

Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert-Wood Johnson Medical School, Cancer Institute of New Jersey, New Brunswick, USA.

出版信息

Chest. 1995 Jun;107(6 Suppl):332S-344S. doi: 10.1378/chest.107.6_supplement.332s.

DOI:10.1378/chest.107.6_supplement.332s
PMID:7781415
Abstract

Malignant mesothelioma of the pleura occurs primarily in individuals who were exposed to asbestos either in the workplace or home. The incidence of malignant mesothelioma is rising and, reflective of the malignancy's long latency period, is expected to continue to increase into the next century. Current treatment measures, including surgery, radiation therapy, chemotherapy, intrapleural therapy, and combined-modality therapies, have had varying impacts on survival. This paper explores current trends in the treatment of malignant pleural mesothelioma.

摘要

胸膜恶性间皮瘤主要发生在那些在工作场所或家中接触过石棉的人身上。恶性间皮瘤的发病率正在上升,鉴于这种恶性肿瘤的潜伏期很长,预计在下个世纪还会继续上升。目前的治疗措施,包括手术、放射治疗、化疗、胸膜内治疗以及综合治疗,对生存率产生了不同程度的影响。本文探讨了恶性胸膜间皮瘤治疗的当前趋势。

相似文献

1
Current approach to malignant mesothelioma of the pleura.胸膜恶性间皮瘤的当前治疗方法。
Chest. 1995 Jun;107(6 Suppl):332S-344S. doi: 10.1378/chest.107.6_supplement.332s.
2
Malignant mesothelioma 2008.恶性间皮瘤2008年
Curr Opin Pulm Med. 2008 Jul;14(4):303-9. doi: 10.1097/MCP.0b013e328302851d.
3
[Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report].[石棉暴露后发生肾细胞癌合并恶性胸膜间皮瘤:一例报告]
Hinyokika Kiyo. 2007 Nov;53(11):805-8.
4
[Malignant mesothelioma of the pleura: place of surgery].[胸膜恶性间皮瘤:手术的地位]
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S106-10S109.
5
Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.恶性胸膜间皮瘤行胸膜外肺切除术后的结果。
Eur J Cardiothorac Surg. 2008 Jul;34(1):204-7. doi: 10.1016/j.ejcts.2008.03.003. Epub 2008 Apr 14.
6
Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management.我们是否应该继续为特定的间皮瘤患者提供胸膜外全肺切除术?一项比较手术治疗和非手术治疗的单中心经验。
Jpn J Clin Oncol. 2014 Nov;44(11):1127-9. doi: 10.1093/jjco/hyu134. Epub 2014 Sep 3.
7
Benign and malignant pleural mesothelioma.良性和恶性胸膜间皮瘤。
Clin Chest Med. 1985 Mar;6(1):127-40.
8
Pleuropneumonectomy: an effective treatment modality for malignant pleural mesothelioma?胸膜肺切除术:治疗恶性胸膜间皮瘤的有效治疗方式?
Ann Thorac Cardiovasc Surg. 2008 Jun;14(3):135-7.
9
[Two cases of malignant mesothelioma controlled by pleurectomy].[两例经胸膜切除术控制的恶性间皮瘤]
Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Nov;30(11):1996-2001.
10
[Treatment of malignant pleural mesothelioma--present status and future view].[恶性胸膜间皮瘤的治疗——现状与未来展望]
Fukuoka Igaku Zasshi. 2008 Apr;99(4):74-9.

引用本文的文献

1
Imaging Features of Various Benign and Malignant Tumors and Tumorlike Conditions of the Pleura: A Pictorial Review.胸膜各种良性和恶性肿瘤及肿瘤样病变的影像学特征:图谱综述
Taehan Yongsang Uihakhoe Chi. 2020 Sep;81(5):1109-1120. doi: 10.3348/jksr.2019.0165. Epub 2020 Aug 13.
2
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.免疫相关不良反应与尼伏单抗治疗恶性胸膜间皮瘤患者的疗效相关性。
BMC Pulm Med. 2021 Nov 15;21(1):373. doi: 10.1186/s12890-021-01746-6.
3
Physician requests by patients with malignant pleural mesothelioma in Japan.
日本恶性胸膜间皮瘤患者的医师申请。
BMC Cancer. 2019 Apr 25;19(1):383. doi: 10.1186/s12885-019-5591-7.
4
Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma.132例恶性间皮瘤患者的临床特征及治疗结果
Lung India. 2011 Oct;28(4):267-71. doi: 10.4103/0970-2113.85688.
5
Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.胸膜间皮瘤通过恶性细胞因子网络诱导肿瘤相关成纤维细胞促进肿瘤进展。
Am J Pathol. 2011 Sep;179(3):1483-93. doi: 10.1016/j.ajpath.2011.05.060. Epub 2011 Jul 18.
6
Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.双时间点氟代脱氧葡萄糖正电子发射断层显像(FDG-PET)成像在鉴别恶性与良性胸膜疾病中的潜力
Mol Imaging Biol. 2009 Sep-Oct;11(5):369-78. doi: 10.1007/s11307-009-0212-5. Epub 2009 May 27.
7
A case of solid pseudopapillary tumour of the pancreas and malignant mesothelioma.一例胰腺实性假乳头状肿瘤合并恶性间皮瘤。
J Gastrointest Cancer. 2007;38(2-4):71-3. doi: 10.1007/s12029-008-9032-0. Epub 2008 Oct 18.
8
Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso.使用肺癌症状量表(LCSS)的修订版测量胸膜间皮瘤患者的生活质量:LCSS-Meso的心理测量特性。
Support Care Cancer. 2006 Jan;14(1):11-21. doi: 10.1007/s00520-005-0837-0. Epub 2005 Jul 6.
9
Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: results of a single center in central anatolia.异环磷酰胺、美司钠和α-干扰素2A联合化疗免疫疗法治疗恶性间皮瘤:安纳托利亚中部某单中心的研究结果
Med Oncol. 2004;21(4):359-66. doi: 10.1385/MO:21:4:359.
10
Glutathione S-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study.谷胱甘肽S-转移酶在恶性间皮瘤和非肿瘤性间皮中的表达:一项免疫组织化学研究
J Cancer Res Clin Oncol. 1996;122(10):619-24. doi: 10.1007/BF01221194.